Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

Ensaio clínico

The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

NCT: NCT05886348 · ACTIVE_NOT_RECRUITING

ID NCTNCT05886348
EstadoACTIVE_NOT_RECRUITING
Data de início2023-07-31
Conclusão2027-05-31
SponsorHOYA Lens Thailand LTD. (INDUSTRY)
First posted
Last updated

Resumo breve

The goal of this clinical trial is to test Novel spectacle lenses in myopic children. The main question it aims to answer are: safety and efficacy of the lenses. Participants will be asked to wear spectacles and participate in eye exams and questionnaires. Researchers will compare Novel spectacle lenses and general single vision spectacle lenses to see if the Novel spectacle lenses correct myopic ametropia, slow the progression of myopia and axial elongation.

Fonte oficial

Ver no ClinicalTrials.gov →

Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.

↑